Multiparametric MRI is one of the latest and most effective tools employed to detect prostate cancer. It supplements ordinary MRI scans with additional imaging in order to provide radiologists with detailed anatomical information about the patient’s prostate gland. If a tumor is detected, multiparametric MRI allows radiologists to measure its size, map its position, determine its stage, estimate its Gleason score, and check whether it has spread beyond the prostate.
PSA (Prostate Specific Antigen) screening has been a valuable but imprecise method of detecting prostate cancer. However, a new study indicates that measuring PSA density (PSAD) may identify men who are low cancer risks, sparing them from unnecessary tests and biopsies. Read more to see how PSAD testing can help men stay on top of their health.
A 25-year study has found the prostate drug finasteride lowers cancer deaths. Learn more about this potentially life-saving breakthrough and why doctors have struggled to get it approved by the FDA.
In order to raise awareness of Prostate Cancer Month, Dr. Princenthal recently visited KCAL-9 to talk about some of the issues involved in the prevention and treatment of prostate cancer. It’s the second most common cancer among men, with over 220,000 new cases every year, yet many men aren’t aware of how to protect themselves with basic screening techniques, like the PSA blood test or prostate MRI.
The US Preventative Services Task Force recently revised its guidelines on prostate specific antigen (PSA) screening. It recommended that healthy men forgo the procedure, regardless of their age. However, studies have found that regular PSA screenings, combined with prostate MRI and physical exams, reduces the number of benign biopsies performed on patients. Dinner will be graciously provided by Rolling Oaks Radiology Thousand Oaks.